June 28, 2023, YSB Inc. (“YSB“, stock code: 9885) is listed on the Main Board of Hong Kong Stock Exchange. Fangda acted as YSB’s PRC legal counsel and data compliance legal counsel for this listing, provided legal services for the entire listing process from PRC legal perspectives.

Since 2015, YSB has operated the “YSB Platform”, a digital pharmaceutical platform serving businesses outside of hospitals. According to relevant industry consultant’s report, YSB is the largest digital pharmaceutical platform serving businesses outside of hospitals in China, of which the gross merchandise value reached RMB 37.8 billion in 2022, and YSB also serves the largest digital pharmaceutical transaction and service network, including, among others, around 354,000 downstream pharmacies and around 173,000 primary healthcare institutions, as of 31 December 2022.

Fangda is committed to continuously empowering enterprises by providing “one-stop” legal services. As part of this commitment, Fangda is pleased to have cooperated with YSB and to have witnessed YSB’s great business success. During this years-long cooperation, Fangda has provided YSB with high-quality professional legal services on the area of corporate finance and capitalization matters.

The team advising on this transaction was led by partners Jeffrey Ding and Patrick Li, and team members included Emily Xue, Esther Wu, Hale Lu, Scarlett Chang, Churchill Yin, Ariel Yuan and Lewis Liu. Data compliance partner Gil Zhang also supported this transaction, providing legal advice on data compliance and cybersecurity. Data compliance team included Patrick Guo, David Ye and Yanbin Liu.